BETA PHARMA, INC.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 30, 2018 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 20 Total Citation Count
- Mar 26, 2003 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9878994 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereofJul 24, 15Jan 30, 18[A61K, C07D]
9820721 Aspiration and biopsy needle apparatus and devices and applications thereofApr 23, 15Nov 21, 17[A61B]
9730921 Compositions and methods for the prevention and treatment of mast cell-induced vascular leakageMar 15, 13Aug 15, 17[A61K, A01N, G01N]
9359370 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereofJul 31, 14Jun 07, 16[A61K, C07D]
8822482 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereofJul 07, 09Sep 02, 14[A61K, C07D]
7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitorsMar 26, 03Jul 18, 06[A61K]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.